| Safeway Pharmacy #3265 | |
| 106 W Manson Hwy, Chelan, Washington 98816 | |
| (509) 682-4087 |
| Name | Safeway Pharmacy #3265 |
|---|---|
| Organization Name | Safeway Inc |
| Location | 106 W Manson Hwy, Chelan, Washington 98816 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (509) 682-4087 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
In primary care settings, training and support of clinicians has a lasting effect on the proportion of adult patients given an alcohol intervention at nine months.
D-Pharm Ltd announced enrollment of patients with acute ischemic stroke into its Phase III clinical study of DP-b99 (MACSI). The first patient has been enrolled at the Wolfson Medical Center, Israel. The MACSI trial involves numerous medical centers in the US, Canada, Europe, Israel, South Africa, South Korea and Brazil. DP-b99 is D-Pharm's most advanced product developed for protection of brain cells suffering from restricted blood and oxygen supply (ischemia).
A study presented at this year's American Society of Anesthesiologists (ASA) Annual Meeting demonstrated that the use of the sedative Dexmedetomidine was safe and reduced the amount of time for the extubation process, or the process of removing a tube from the airway of critically ill patients.
Cell Therapeutics, Inc. announced that Dr. Richard Van der Jagt of the Ottawa General Hospital will present at the Lymphoma and Myeloma 2009 Conference in New York an overview of CTI's pixantrone phase II and phase III clinical studies that demonstrated high rates of complete remission (CR) in relapsed/refractory aggressive and indolent non-Hodgkin's lymphoma (NHL) patients.
› Verified 1 days ago
| NPI Number | 1063441087 |
| Organization Name | SAFEWAY INC |
| Doing Business As | SAFEWAY PHARMACY #3265 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 106 W Manson Hwy, Chelan, WA 98816 |
| Phone Number | 509-682-4087 |
News Archive
In primary care settings, training and support of clinicians has a lasting effect on the proportion of adult patients given an alcohol intervention at nine months.
D-Pharm Ltd announced enrollment of patients with acute ischemic stroke into its Phase III clinical study of DP-b99 (MACSI). The first patient has been enrolled at the Wolfson Medical Center, Israel. The MACSI trial involves numerous medical centers in the US, Canada, Europe, Israel, South Africa, South Korea and Brazil. DP-b99 is D-Pharm's most advanced product developed for protection of brain cells suffering from restricted blood and oxygen supply (ischemia).
A study presented at this year's American Society of Anesthesiologists (ASA) Annual Meeting demonstrated that the use of the sedative Dexmedetomidine was safe and reduced the amount of time for the extubation process, or the process of removing a tube from the airway of critically ill patients.
Cell Therapeutics, Inc. announced that Dr. Richard Van der Jagt of the Ottawa General Hospital will present at the Lymphoma and Myeloma 2009 Conference in New York an overview of CTI's pixantrone phase II and phase III clinical studies that demonstrated high rates of complete remission (CR) in relapsed/refractory aggressive and indolent non-Hodgkin's lymphoma (NHL) patients.
› Verified 1 days ago
News Archive
In primary care settings, training and support of clinicians has a lasting effect on the proportion of adult patients given an alcohol intervention at nine months.
D-Pharm Ltd announced enrollment of patients with acute ischemic stroke into its Phase III clinical study of DP-b99 (MACSI). The first patient has been enrolled at the Wolfson Medical Center, Israel. The MACSI trial involves numerous medical centers in the US, Canada, Europe, Israel, South Africa, South Korea and Brazil. DP-b99 is D-Pharm's most advanced product developed for protection of brain cells suffering from restricted blood and oxygen supply (ischemia).
A study presented at this year's American Society of Anesthesiologists (ASA) Annual Meeting demonstrated that the use of the sedative Dexmedetomidine was safe and reduced the amount of time for the extubation process, or the process of removing a tube from the airway of critically ill patients.
Cell Therapeutics, Inc. announced that Dr. Richard Van der Jagt of the Ottawa General Hospital will present at the Lymphoma and Myeloma 2009 Conference in New York an overview of CTI's pixantrone phase II and phase III clinical studies that demonstrated high rates of complete remission (CR) in relapsed/refractory aggressive and indolent non-Hodgkin's lymphoma (NHL) patients.
› Verified 1 days ago
Lake Chelan Pharmacy Inc Type: Pharmacy Location: 223 E Johnson Ave, Chelan, Washington 98816 Phone: (509) 682-2751 | |
Safeway Pharmacy #3265 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 106 W Manson Hwy, Chelan, Washington 98816 Phone: (509) 682-4087 | |
Walmart Pharmacy 10-3754 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 108 Apple Blossom Dr, Chelan, Washington 98816 Phone: (509) 682-4634 |